Floatz logo

TENOFOVIR DISOPROXIL FUMARATE

Chronic Hepatitis B

Ningbo No.2 HospitalSmall moleculePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
89/ 100

Competitive context

12 Active assets in the Chronic Hepatitis B cohort.

Asset / SponsorPhaseRating
Entecavir
Beijing Continent Pharmaceutical Co, Ltd.
Phase 4BBB
Lamivudine
Yonsei University
Phase 4BBB
Telbivudine
The Fifth People's Hospital of Suzhou
Phase 4BBB
Pegylated Interferon Alpha2A
Huashan Hospital
Phase 4BB
Tenofovir Alafenamide
Ningbo No.2 Hospital
Phase 4BB

View all 29 →

Same molecule, other indications

TENOFOVIR DISOPROXIL FUMARATE is also rated in:

HIV infectious diseaseDormant
BBB
Indicative ·
72 / 100
View asset →
lipodystrophyDormant
BB
Indicative ·
69 / 100
View asset →
HIV infectious diseaseDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →